ARA290

Metabolic Research Peptide

ARA-290, also known as Cibinetide, is a synthetic 11-amino-acid peptide studied in laboratory research involving cellular signaling, tissue-protective pathways, and inflammatory responses.

For laboratory research use only. Not for human or veterinary use.

★Earn 800 Rewards Points

How Rewards Work

Original price was: $50.00.Current price is: $40.00.

Description

ARA-290 (Cibinetide) is a synthetic peptide derived from the helix-B region associated with erythropoietin research. It has been investigated experimentally for its interactions with tissue-protective signaling pathways and cellular responses.

Research Areas

Cellular signaling research
Tissue-protective pathways
Inflammatory response research
Cellular stress responses
Peptide receptor interactions
Product Details

Product Name: ARA-290
Alternative Name: Cibinetide
Other Names: ARA290, PHBSP, pHBSP
Peptide Length: 11 amino acids
Sequence: XEQLERALNSS (X represents pyroglutamate)
Molecular Formula: C₅₁H₈₄N₁₆O₂₁
Molecular Weight: 1257.3 g/mol
CAS Number: 1208243-50-8
PubChem CID: 91810664
Type: Synthetic Research Peptide

Important Information: This product is intended strictly for laboratory and scientific research. It is not intended for human or veterinary consumption or for the diagnosis, treatment, cure, or prevention of disease.

Additional information

Weight 0.2 lbs
Dimensions 2 × 2 × 2 in
Strength

10mg

Reviews

There are no reviews yet.

Be the first to review “ARA290”

Your email address will not be published. Required fields are marked *

All Evere Wellness products are intended solely for laboratory and scientific research. Not for human or veterinary consumption, compounding, diagnosis, treatment, cure, or prevention of disease.

Evere Wellness does not provide medical advice, dosing instructions, or treatment recommendations. These statements have not been evaluated by the Food and Drug Administration. These products are not drugs and are not intended to diagnose, treat, cure, or prevent any disease.

66ee6a6d 58d3 40c0 b979 034db2a09261

Subscribe to our

Newsletter

Subscribe to our newsletter to get daily insights, news, updates.